Rankings
▼
Calendar
AMRN Q4 2019 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$143M
+85.3% YoY
Gross Profit
$113M
78.6% margin
Operating Income
$5M
3.8% margin
Net Income
$7M
4.9% margin
EPS (Diluted)
$0.40
QoQ Revenue Growth
+27.5%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$882M
Total Liabilities
$274M
Stockholders' Equity
$608M
Cash & Equivalents
$645M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$143M
$77M
+85.3%
Gross Profit
$113M
$60M
+88.2%
Operating Income
$5M
-$32M
+117.3%
Net Income
$7M
-$34M
+121.0%
Revenue Segments
Product
$142M
99%
License
$1M
1%
← FY 2019
All Quarters
Q1 2020 →